Ann: Landmark Research on Excess Cortisol & Alzheimer's Disease-ACW.AX, page-17

This is likely due to the fact that there are a number of “could” “may” and “if” statements within the announcement which obviously wouldn’t fill people with confidence. Let’s face it, things are still in trail stages and it was also mentioned that there is unlikely to be a “magic bullet” to this disease.  Actinogen have a theory, have very experienced and respected personnel in the industry and are waiting approvals to take this theory further… it’s a long game and even says so in the announcement  (4yrs and that’s if it’s plain sailing). It’s no wonder it hasn’t taken off yet and personally I don’t see it doing so in the near future and obviously the market thinks the same. Ultimately (depending on your strategies of course) it’s not a bad thing; if you believe in the company then it gives you more time to save up and put you money where your mouth is! I don’t mind supporting a few slow burners if they get there in the end!